Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08GIM
|
||||
Former ID |
DIB013107
|
||||
Drug Name |
Elisidepsin
|
||||
Synonyms |
Irvalec; Elisidepsin trifluoroacetate; PM-02734; Erbb3 tyrosine kinase receptor inhibitor (cancer), PharmaMar; Kahalalide therapy (solid tumor), PharmaMar
|
||||
Indication | Psoriasis [ICD9: 696; ICD10:L40] | Phase 2 | [533234] | ||
Company |
PharmaMar SA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C77H125F3N14O18
|
||||
Canonical SMILES |
N1(C(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(<br />=O)CC[C@H](CC)C)C(C)C)[C@H](O)C)C(C)C)C(C)C)[C@@H](C(=O<br />)N[C@H](C(=O)N[C@@H](C(=O)N[C@H]2C(=O)N[C@@H](C(=O)N[C@<br />@H](C(=O)N[C@H](C(=O)N/C(=C\C)/C(=O)N[C@H](C(=O)O[C@@H]<br />2C)C(C)C)Cc2ccccc2)C(C)C)[C@H](CC)C)[C@H](CC)C)CCCN)CCC<br />1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Receptor protein-tyrosine kinase erbB-3 | Target Info | Inhibitor | [530057] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
PANTHER Pathway | Cadherin signaling pathway | ||||
EGF receptor signaling pathway | |||||
Pathway Interaction Database | ErbB2/ErbB3 signaling events | ||||
ErbB receptor signaling network | |||||
a6b1 and a6b4 Integrin signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.